Insulet CR
Sector: Manufacturing (Industrial) • Location: Costa Rica
Source: International Finance Corporation (IFC)
Insulet Corporation () (“Insulet” or the “Company”) is a MedTech company, specializing in diabetes management solutions. The Company is planning to establish its first manufacturing facility in Latin America, dedicated to the production of its flagship product, the Omnipod® insulin management system, a tubeless insulin delivery device for people living with diabetes. The ne
- Status
- Prospective
- Sector
- Manufacturing (Industrial), Warehouse, Hospital, Raw Materials
- Location
- Costa Rica
- Updated
- 22 Jul 2026
- Source
- International Finance Corporation (IFC)
ConstructChat
Ask ConstructChat about Insulet CR
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | active |
Taiyo status | Prospective |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Insulet Corporation (https://www.insulet.com/) (“Insulet” or the “Company”) is a MedTech company, specializing in diabetes management solutions. The Company is planning to establish its first manufacturing facility in Latin America, dedicated to the production of its flagship product, the Omnipod® insulin management system, a tubeless insulin delivery device for people living with diabetes. The new manufacturing facility will be located within Savia Sur, a light industrial park in Heredia, Costa Rica, developed by Portafolio Inmobiliario (“Portafolio” or the “Developer”). The site’s former land use consisted of agricultural land, specifically a coffee plantation, and it is classified as modified habitat. The proposed IFC investment consists of a corporate A-loan of US$97 million, to support the construction of the facility’s cold-shell (the “Project”). The Borrower will be 3-101-939148 SA (“Savia SPV”), a special purpose vehicle responsible for managing the assets of the industrial park where the plant will be located. This SPV will be responsible for constructing the cold shell. Savia SPV is owned by the Developer and the original owners of the land. Construction is expected to progress over the 2026-2028 period. Operations are expected to go-live in 2029. |
Original sector | M-IA - Medical Equipment and Supplies Manufacturing |
Location
Country | Costa Rica |
Source
Source | International Finance Corporation (IFC) |
URL |
More Details
Record type | Project |
Sector | Manufacturing (Industrial), Warehouse, Hospital, Raw Materials |
Article published date | 2026-06-08 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
